GSK PLC ADR
2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30
보유 슈퍼인베스터
| 슈퍼인베스터 | 보유수량 | 평가액 | 비중 | 구분 |
|---|---|---|---|---|
| 도지 앤 콕스 펀즈 | 48,197,514 | $2.527B | 1.3% | 축소 |
| 칸 브라더스 그룹 | 158,438 | $8.305M | 1.3% | 축소 |
| 힐만 캐피털 매니지먼트 | 92,383 | $4.843M | 3.5% | 축소 |
| 트위디 브라운 | 81,527 | $4.274M | 0.3% | 축소 |
| 프제나 인베스트먼트 매니지먼트 | 24,507 | $1.285M | 0.0% | 추가 |
| 코즈웨이 캐피털 매니지먼트 | 7,163 | $375.5K | 0.0% | 축소 |
분기별
| 분기 | 보유 슈퍼인베스터 | 합계 금액 |
|---|---|---|
| 2022-06-30 | 1 | $11.24M |
| 2022-09-30 | 5 | $1.743B |
| 2022-12-31 | 6 | $2.312B |
| 2023-03-31 | 6 | $2.511B |
| 2023-06-30 | 5 | $2.514B |
| 2023-09-30 | 5 | $2.55B |
| 2023-12-31 | 5 | $2.603B |
| 2024-03-31 | 4 | $2.999B |
| 2024-06-30 | 4 | $2.672B |
| 2024-09-30 | 4 | $2.833B |
| 2024-12-31 | 4 | $2.362B |
| 2025-03-31 | 4 | $3.1B |
| 2025-06-30 | 6 | $3.102B |
| 2025-09-30 | 6 | $3.456B |
| 2025-12-31 | 6 | $3.381B |
| 2026-03-31 | 6 | $3.258B |
| 2026-06-30 | 6 | $2.546B |
| 2026-09-30 | 5 | $2.095B |